The chicken egg white ovoinhibitor, a multi-type proteinase inhibitor, was conjugated with galactomannan through the Maillard reaction in a controlled dry heating state at 609 C and 65% relative humidity. The formation of an ovoinhibitor-galactomannan conjugate during dry heating was conˆrmed by SDS-PAGE. The resulting ovoinhibitor-galactomannan conjugate showed almost the same inhibitory activity toward trypsin, chymotrypsin and elastase as that of the untreated ovoinhibitor, while the conjugate showed stronger heat stability and better emulsifying properties than the untreated ovoinhibitor. These results suggest that the ovoinhibitor-galactomannan conjugate can be used as a protease inhibitor having heat stability and outstanding emulsifying properties for industrial application.
The chicken egg white ovoinhibitor is a serine proteinase inhibitor comprising seven domains that are responsible for the inhibition of trypsin, chymotrypsin and elastase. The ovoinhibitor is produced from the tubular gland cell of the oviduct of laying hens and is present in chicken egg white at about one tenth the amount of ovomucoid. 1) Theˆrst four domains potentially inhibit trypsin, theˆfth, chymotrypsin, and the sixth and seventh domains could inhibit elastase and chymotrypsin.
2) Davis et al. 3) have observed that the ovoinhibitor might inhibit microbial protease, as the animal protease shares a similar structure. Tomimatsu, Clary & Bartulovich 4) have also observed that chymotrypsin and subtilisin competed for the same site of the ovoinhibitor. Therefore, the ovoinhibitor can be used as an antimicrobial ingredient for industrial application. We have already reported that Maillard-type proteinpolysaccharide conjugates can be used as a new functional biopolymer having outstanding emulsifying properties and heat stability. [5] [6] [7] [8] [9] [10] Maillardtype protein-polysaccharide conjugates can be e‹ciently prepared during heat-storage of the freezedried powder of protein-polysaccharide mixtures in a controlled dry state without the use of chemical reagents. The Maillard reaction between the e-amino group in protein and the reducing-end carbonyl group in a polysaccharide is accelerated with low water activity, and the rate of reaction is dependent on the conformation of the proteins. The typical unfolded protein, as-casein, easily formed a polysaccharide conjugate, and four lysyl residues reacted with the polysaccharide within 24 h. 8) In contrast, the rigidly folded lysozyme slowly formed a polysaccharide conjugate and only one or two lysyl residues reacted with polysaccharide even after 2 weeks with a small loss of lytic activity. 7) This limitation of the binding site of a polysaccharide is favorable for maintaining the protein structure and function. Since the ovoinhibitor has a rigid conformation, binding of the polysaccharide may occur at limited sites and can be expected to bring about new functional properties. Thus, an attempt was carried out to prepare an ovoinhibitor-galactomannan conjugate through the Maillard reaction.
Materials and Methods
Preparation of the ovoinhibitor from chicken egg white. The ovoinhibitor-rich fraction was separated from the precipitate with 0.4 saturated ammonium sulfate in fresh chicken egg white.
3) The crude ovoinhibitor was then applied to a DEAE-Sepharose fast‰ow column (2.5×54 cm) that had been equilibrated with a 10 mM Tris-HCl buŠer (pH 8.0). The same buŠer was used to wash the column. Tris-HCl buŠers containing 0.1, 0.2 and 0.3 M NaCl were used stepwise to elute the adsorbed protein. The protein fraction eluted with 0.3 M NaCl was further puriˆed in the same column with a 0-0.3 M NaCl gradient in the 10 mM Tris-HCl buŠer (pH 8.0). The resulting protein fraction was used for the experiments.
Preparation of the ovoinhibitor-galactomannan conjugate. A galactomannan preparation (MW 15,000-20,000) was obtained by dialyzing the mannase hydrolyzate of guar gum supplied by Taiyo Chemicals Co. (Yokkaichi, Japan). An ovoinhibitorgalactomannan mixture in the molar ratio of 1:4 was dissolved in deionized water (pH 6.2) and the solution freeze-dried. The powdered ovoinhibitor-galactomannan mixture was dry-heated for a given time at 609 C and 65z relative humidity in a desiccator containing a saturated KBr solution in the bottom. The resulting ovoinhibitor-galactomannan conjugate was completely soluble and the pH value was 6.0. The conjugate was separated from unbound protein and polysaccharide by ion-exchange chromatography in a DEAE-Sepharose column. The ovoinhibitorgalactomannan conjugate thus obtained was used for the experiments.
SDS-polyacrylamide gel electrophoresis. SDS-PAGE was carried out according to the method of Laemmli, 11) using 15z acrylamide separating gel and 5z stacking gel containing 1z SDS. Samples were heated at 1009 C for 5 min in a Tris-glycine buŠer (pH 8.8) containing 1z SDS and 1z 2-mercaptoethanol. Electrophoresis was carried out at a constant current of 10 mA for 5 h in a Tris-glycine electrophoretic buŠer containing 0.1z SDS. After electrophoresis, the gel sheets were stained for proteins with 0.2z Coomassie brilliant blue R250 and for carbohydrates with a 0.5z periodate-fuchsin solution. The protein and carbohydrate stains were respectively destained with 10z acetic acid containing 20z methanol and deionized water. Densitometric measurement of the ovoinhibitor and ovoinhibitor-galactomannan conjugate was performed with a GS-700 imaging densitometer (Bio Rad, California, U.S.A.).
Measurement of the emulsifying properties. The emulsifying properties of the samples were determined by the method of Pearce & Kinsella. 12) To prepare an emulsion, 1.0 ml of corn oil and 3.0 ml of a 0.1z protein-polysaccharide mixture and the conjugate solution in a 0.04 M Tris-HCl buŠer (pH 8.0) were shaken together and homogenized in an Ultra Turrax instrument (Hansen & Co., West Germany) at 12,000 rpm for 1 min at room temperature. A 100 ml aliquot of the emulsion was taken from the bottom of the container at diŠerent times (0, 1, 2, 5 and 10 min) and diluted with 5 ml of a 0.1z SDS solution. The absorbance of the diluted emulsion was then determined at 500 nm. The relative emulsifying activity was determined from the absorbance measured immediately after the emulsion had formed (0 min). The emulsion stability was estimated by measuring the half time of the initial turbidity of the emulsion.
Inhibitory activity of the ovoinhibitor and its galactomannan conjugate. The inhibitory activity of the ovoinhibitor and its galactomannan conjugate was estimated from the SDS-PAGE pattern for the proteolytic peptide degradation of serum albumin as a substrate after trypsin, chymotrypsin and elastase proteolysis for 30 min at 379 C. The protease reactions in the presence of the ovoinhibitor and its conjugate were started by adding the substrate after preincubating the inhibitor with the corresponding enzyme in a 0.04 M Tris-HCl buŠer (pH 8.0) for 5 min. The inhibitory activity is presented as the percentage decrease in density of the band for serum albumin between the presence and absence of the corresponding protease.
Heat stability of the ovoinhibitor and its galactomannan conjugate. The ovoinhibitor and its galactomannan conjugate were heated to an increasing temperature over 70, 80, 90, and 1009 C in the 0.04 M Tris-HCl buŠer (pH 8.0). After heating, the inhibitory activity against each protease was measured.
Results

SDS-PAGE of the ovoinhibitor and ovoinhibitorgalactomannan conjugate
The SDS-PAGE pattern of the ovoinhibitor is shown in Fig. 1 . Although the fraction was puriˆed by a‹nity chromatography in a chymotrypsin-Sepharose column, two bands were still apparent (data not shown). In order to prepare the ovoinhibitor-galactomannan conjugate, the ovoinhibitorgalactomannan mixture (molar ratio of 1:4) was dissolved in deionized water and then lyophilized. Interestingly, the band of the nonglycosylated ovoinhibitor disappeared after lyophilizing the mixture, as shown in Fig. 1 (lane 2) . This result suggested that the nonglycosylated ovoinhibitor had strong a‹nity to galactomannan and could be removed as an insoluble aggregate after lyophilization with galactomannan. The presence of an aggregate was conˆrmed in freeze-dried powder of the ovoinhibitor-galactomannan mixture, and the SDS-PAGE pattern of the aggregate showed the presence of a high content of the non-glycosylated ovoinhibitor, in addition to bands of greater molecular size (Fig. 1, lane 3) . Therefore, the glycosylated ovoinhibitor (lane 2) was used for conjugating with galactomannan. The formation of a covalently bound ovoinhibitor-galactomannan conjugate through the Maillard reaction was conˆrmed by SDS-PAGE. The ovoinhibitorgalactomannan conjugate was formed during dry heating at 609 C and 65z relative humidity for 3, 7, or 10 days, as shown in Fig. 2 (left panel), lanes 2, 3  and 4 , respectively. The protein band of the native ovoinhibitor was converted into the bands of greater molecular size of a protein-polysaccharide conjugate. The galactomannan attachment to the ovoinhibitor was further conˆrmed by the SDS-PAGE pattern of carbohydrate-speciˆc staining (Fig. 2, right panel) . The carbohydrate-stained bands of high molecular size increased with dry heating. Most of the ovoinhibitor had become conjugated with galactomannan after 10 days of dry heating. An apparent increase in the band of the ovoinhibitor-galactomannan conjugate was observed near the boundary between the stacking and separating gel, and on the top of the stacking gel. A marked increase in the carbohydrate-stained band after dry heating for three days indicates the attachment of small molecular size galactomannan, because galactomannan has many reactive sites to carbohydrate staining reagent.
Calculated from the decrease in free amino groups in the ovoinhibitor, about two to three molecules of galactomannan had been attached to one molecule of the ovoinhibitor. This is consistent with the SDS-PAGE pattern of the ovoinhibitor-galactomannan conjugate, although the band was broader, re‰ecting the broad molecular weight distribution of galactomannan.
Emulsifying properties of the ovoinhibitor-galactomannan conjugate
Changes in the turbidity of emulsions of the ovoinhibitor-galactomannan mixture and conjugate are shown in Fig. 3 . The emulsifying properties of the ovoinhibitor were greatly increased with the dryheating time. The relative emulsifying activity and emulsion stability of the ovoinhibitor-galactomannan conjugate were estimated from thisˆgure (Table 1 ). The ovoinhibitor-galactomannan conjugate exhibited greater emulsifying activity and emulsion stability than that of the ovoinhibitorgalactomannan mixture. The emulsion stability of the conjugates obtained after 7 and 10 days were respectively 2.5 and 5 times higher than that of the mixture. The emulsifying properties of the ovoinhibitor-galactomannan mixture were relatively higher than those of other protein-galactomannan mixtures. This may have been due to the N-linked glycosylation of the ovoinhibitor. On the other hand, the emulsion stability of the ovoinhibitor-galactomannan mixture was not as high as that of the conjugates. Conjugation of the ovoinhibitor with galactomannan was found very eŠective for enhancing the emulsion stability. Heat stability of the ovoinhibitor-galactomannan conjugate
The inhibitory activities of the ovoinhibitor against trypsin, chymotrypsin and elastase were completely retained after conjugation with galactomannan. Although the ovoinhibitor is a relatively heat-stable protein similarly to other protease inhibitors, it seemed to be less stable to heating, because it was composed of multi-type protease inhibitory domains. Therefore, the heat stability was expected to be improved by the conjugation with galactomannan. Figure 4 shows the trypsin inhibitory activity of the ovoinhibitor and its galactomannan conjugate that had been dry-heated for 10 days. The inhibitory activity was measured from the change in the band on the SDS-PAGE pattern of the substrate, bovine serum albumin, during the protease reaction. Although both the ovoinhibitor and its galactomannan conjugate showed heat stability upto 809 C, the ovoinhibitor-galactomannan conjugate was more heat-stable than the untreated ovoinhibitor. The ovoinhibitor-galactomannan conjugate showed 80z inhibitory activity even after heating at 1009 C. Figure 5 shows the chymotrypsin inhibitory activity of the ovoinhibitor and its galactomannan conjugate that had been dry-heated for 10 days. The ovoinhibitor-galactomannan conjugate showed better heat stability than the untreated ovoinhibitor in a similar manner to that shown in Fig. 4 . The ovoinhibitor-galactomannan conjugate showed 60z inhibitory activity after heating at 1009 C. Figure 6 shows the elastase inhibitory activity of the ovoinhibitor and its galactomannan conjugate that had been dry-heated for 10 days. The ovoinhibitor-galactomannan conjugate showed better heat stability than the untreated ovoinhibitor in a similar manner to that shown in Figs. 4 and 5. However, although the ovoinhibitor-galactomannan conjugate retained 75z inhibitory activity after heating at 909 C, this decreased to 20z inhibitory activity on heating at 1009 C.
The inhibitory domains of trypsin, chymotrypsin and elastase in the ovoinhibitor are located in that order from the N-terminal to the C-terminal. The heat stability also decreased in this order, regardless of the galactomannan attachment. This suggests that the domains at the C-terminal were less stable than those at the N-terminal. The molecular mechanism needs to be further elucidated.
Discussion
Although some researchers have reported the properties of the chicken egg white ovoinhibitor, there is little information on the puriˆcation of the ovoinhibitor despite the many reports. Davis et al. 3) have reported that the ovoinhibitor consisted of three broad bands with an average molecular size of 46,500. Feinstein 13) has reported that the ovoinhibitor puriˆed by a‹nity chromatography in a chymotrypsin-sepharose column had a molecular weight of 52,400 calculated from the result of an ultracentifugation analysis; however, the author did not describe the homogeneity. Although we tried the same a‹nity chromatography to purify the ovoinhibitor, it was di‹cult to separate its two components, as shown in Fig. 1 . This suggests that the ovoinhibitor consisted of nonglycosylated and glycosylated forms. It is interesting that the nonglycosylated ovoinhibitor could be easily removed by lyophilizing its mixture with galactomannan, because puriˆcation of the ovoinhibitor was otherwise very di‹cult.
The ovoinhibitor-galactomannan conjugate showed improved emulsifying properties and emulsion stability, while also exhibiting strong heat stability. This heat stability may be attributable to the enhanced reversibility resulting from the suppression of aggregation of the unfolded form due to the attached polysaccharide.
14) The ovoinhibitor-galactomannan conjugate may play an important role in protecting from microorganisms. The inhibition of microbial protease may be the natural function of the ovoinhibitor, so the ovoinhibitor-galactomannan conjugate could be used as an antimicrobial ingredient for industrial applications due to its heat stability and high emulsifying properties. Saxena and Tayyab 15) have reported that the ovoinhibitor did not inhibit the proteolytic activity of pepsin, so it is probable that the ovoinhibitor-galactomannan conjugate is digested in the stomach. Another advantage is that the conjugation of an allergen protein with a polysaccharide may be eŠective for reducing allergenicity by masking the allergenic structure reported by Babiker et al.
16) The ovoinhibitor may induce an allergenic reaction, and this allergenicity could be reduced by forming an ovoinhibitor-galactomannan conjugate. It can therefore be concluded that the ovoinhibitorgalactomannan conjugate might provide some advantages for the food industry.
